The impact of Lacticaseibacillus paracasei GMNL-143 toothpaste on gingivitis and oral microbiota in adults: a randomized, double-blind, crossover, placebo-controlled trial

Min Kang Lee, I. Hui Chen, I. Ling Hsu, Wan Hua Tsai, Tzong Yi Lee, Jhih Hua Jhong, Bai Chia Liu, Tsui Yin Huang, Fang Kuei Lin, Wen Wei Chang*, Ju Hui Wu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: This study examines the oral health benefits of heat-killed Lacticaseibacillus paracasei GMNL-143, particularly its potential in oral microbiota alterations and gingivitis improvement. Methods: We assessed GMNL-143’s in vitro interactions with oral pathogens and its ability to prevent pathogen adherence to gingival cells. A randomized, double-blind, crossover clinical trial was performed on gingivitis patients using GMNL-143 toothpaste or placebo for four weeks, followed by a crossover after a washout. Results: GMNL-143 showed coaggregation with oral pathogens in vitro, linked to its surface layer protein. In patients, GMNL-143 toothpaste lowered the gingival index and reduced Streptococcus mutans in crevicular fluid. A positive relationship was found between Aggregatibacter actinomycetemcomitans and gingival index changes, and a negative one between Campylobacter and gingival index changes in plaque. Conclusion: GMNL-143 toothpaste may shift oral bacterial composition towards a healthier state, suggesting its potential in managing mild to moderate gingivitis. Trial registration: ID NCT04190485 (https://clinicaltrials.gov/); 09/12/2019, retrospective registration.

Original languageEnglish
Article number477
JournalBMC Oral Health
Volume24
Issue number1
DOIs
StatePublished - Dec 2024

Keywords

  • Gingivitis
  • Lacticaseibacillus paracasei
  • Oral microbiota
  • Probiotic toothpaste

Fingerprint

Dive into the research topics of 'The impact of Lacticaseibacillus paracasei GMNL-143 toothpaste on gingivitis and oral microbiota in adults: a randomized, double-blind, crossover, placebo-controlled trial'. Together they form a unique fingerprint.

Cite this